Expert Guidance on Current and Future Therapeutic Strategies for Multiple Myeloma

Review the latest data and expert guidance to enhance your treatment of multiple myeloma! This comprehensive program features focused commentaries, a downloadable treatment resource, updates to our interactive treatment decision support tool, and text-based and video-based learning modules along with downloadable slides.
Sarah A. Holstein, MD, PhD
Suzanne Lentzsch, MD, PhD
Elisabet E. Manasanch, MD

ClinicalThought

Are you up to date on the latest information on frontline induction, consolidation, and maintenance regimens for patients with newly diagnosed myeloma?

Elisabet E. Manasanch, MD Released: August 9, 2019

New approaches promise to transform care in multiple myeloma again. Read my thoughts on the most promising novel agents in clinical trial!

Sarah A. Holstein, MD, PhD Released: October 30, 2019

Gain practical insights for your care of patients with relapsed/refractory myeloma

Elisabet E. Manasanch, MD Released: January 31, 2020

Suzanne Lentzsch, MD, PhD, talks about her experiences with COVID-19 as she cares for patients with myeloma.

Suzanne Lentzsch, MD, PhD Released: April 28, 2020
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Melissa Velasquez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
AbbVie
Amgen
Celgene Corporation
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Oncopeptides

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue